Clinical pharmacokinetics of sedatives in neonates

Clinical Pharmacokinetics

Volumn 31, Issue 6, 1996, Pages 423-443

  Jacqz Aigrain, Evelyne ^a   Burtin, Pascale ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; DIAZEPAM; FENTANYL; FLUMAZENIL; FLUNITRAZEPAM; LORAZEPAM; MIDAZOLAM; MORPHINE; NALOXONE; OPIATE; PETHIDINE; PROPOFOL; SEDATIVE AGENT; SUFENTANIL; VECURONIUM;

ANALGESIA; APNEA; ARTIFICIAL VENTILATION; BRADYCARDIA; CLINICAL TRIAL; CONVULSION; DOSE CALCULATION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG CHOICE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG RECEPTOR BINDING; HEART ARRHYTHMIA; HUMAN; HYPERBILIRUBINEMIA; HYPOTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; NEUROTOXICITY; NEWBORN DISEASE; ORAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REVIEW; SEDATION; SIDE EFFECT; URINE RETENTION;

EID: 0029844727     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199631060-00003     Document Type: Review

References (131)

1. Truog R, Anand KJS. Management of pain in the post-operative neonate. Clin Perinatol 1989; 16: 61-78
2. Porter F. Pain in the newborn. Clin Perinatol 1989; 16: 549-64
3. Anand KJ, Hickey PR. Halothane-morphine compared with high dose sufentanil for anesthesia and post-operative analgesia in neonatal cardiac surgery. N Engl J Med 1992; 326: 1-9
4. Anand K, Sippel WG, Aynsley-Green A. Randomized trial of fentanyl anesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet 1987; 1: 243-7
5. Roth B, Schlünder C, Houben F, et al. Analgesia and sedation in neonatal intensive care using fentanyl by continuous infusion. Dev Pharmacol Ther 1991; 17: 121-7
6. Greenough A, Morley C, Davis J. Interaction of spontaneous respiration with artificial ventilation in preterm babies. J Pediatr 1983; 103: 764-73
7. Perlman JM, Goodman S, Kreusser KL, et al. Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress syndrome. N Engl J Med 1985; 312: 1353-7
8. Anand KJ, Hickey PR. Pain and its effects in the human neonate and fetus. N Engl J Med 1987; 317: 1321-9
9. McGrath PJ, Johnson G, Goodman JT, et al. CHEOPS: a behavioral scale for rating post-operative pain in children. Adv Pain Res Ther 1985; 9: 395-402
10. Kuttner L, Lepage T. Face scales for the assessment of pediatric pain: a critical review. Can J Behav Sci/Rev Can Sci Comp 1989; 21: 198-209
11. Gauvain-Piquard A, Rodary C, Rezvani A et al. Pain in children aged 2-6 years: a new observational rating scale elaborated in a pediatric oncology unit - preliminary report. Pain 1987; 31: 177-88
12. Jay SM, Ozolins M, Elliott CH. Assessment of children's distress during painful medical procedures. Health Psychol 1983; 2: 133-47
13. Barrier G, Attia J, Mayer MN, et al. Measurement of post-operative pain and narcotic administration in infants using a new clinical scoring system. Intensive Care Med 1989; 15: S37-9
14. Mayers DJ, Hindmarsh KW, Gorecki DKJ, et al. Sedative/ hypnotic effects of chloral hydrate in the neonate: trichloroethanol or parent drug? Dev Pharmacol Ther 1992; 19: 141-6
15. Maloley PA, Gal P, Mize R, et al. Lorazepam dosing in neonates: application of objective sedation scores [letter]. DICP 1990; 24: 326-7
16. Jacqz-Aigrain E, Daoud P, Burtin P, et al. Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn infants. Lancet 1994; 344: 646-50
17. Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-dynamic interface (Pt I). Clin Pharmacokinet 1988; 14: 189-207
18. Morselli PL. Clinical pharmacology in the perinatal period and early infancy. Clin Pharmacokinet 1989; 17 Suppl. 1: 13-28
19. Gilman JT, Gal P. Pharmacokinetic and pharmacodynamic data collection in children and neonates. Clin Pharmacokinet 1992; 23: 1-9
20. Goodman Gilman A, Rall TW, Nies AS, et al., editors. Goodman & Gilman's, the pharmacological basis of therapeutics. New York: Pergamon Press Inc., 1995: 362-73
21. Bailey L, Ward M, Musa MN. Clinical pharmacokinetics of benzodiazepines. J Clin Pharmacol 1994; 34: 804-11
22. Reichelt R, Hofman D, Fodisch HJ, et al. Ontogeny of the benzodiazepine receptor in human brain: fluorographic, immunochemical, and reversible protein binding studies. J Neurochem 1991; 57: 1128-35
23. March D, Shaw CA. Fetal, neonatal, and adult expression of benzodiazepine receptor subtypes in human visual cortex. Eur J Pharmacol 1993; 236: 333-6
24. Langslet A, Meberg A, Bredesen JE, Plasma concentrations of diazepam and N-desmethyldiazepam in newborn infants after intravenous, intramuscular, rectal and oral administration. Acta Paediatr Scand 1978; 67: 99-104
25. Morselli PL, Principi N, Tognoni G, et al. Diazepam elimination in premature and full-term infants and children. J Perinatol Med 1973; 1: 133-41
26. Mandelli M, Morselli PL, Nordio S, et al. Placental transfer of diazepam and its disposition in the newborn. Clin Pharmacol Ther 1975; 17: 564-72
27. Meberg A, Langslet A, Bredesen JE, et al. Plasma concentrations of diazepam and N-desmethyldiazepam in children after a single rectal or intramuscular dose of diazepam. Eur J Clin Pharmacol 1978; 14: 273-6
28. Ackermann E, Richter K. Diazepam metabolism in human fetal and adult liver. Eur J Clin Pharmacol 1977; 11: 43-9
29. Kuhnz W, Nau H. Differences in in vitro binding of diazepam and N-desmethyldiazepam to maternal and fetal plasma proteins at birth: relation to free fatty acid concentration and other parameters. Clin Pharmacol Ther 1983; 34: 220-6
30. Nau H, Luck W, Kuhnz W. Decreased serum protein binding of diazepam and its major metabolite during the first postnatal week relate to increased free fatty acid levels. Br J Clin Pharmacol 1984; 17: 92-8
31. Elliot HW. Metabolism of lorazepam. Br J Anaesth 1976; 48: 1017-23
32. Maytal J, Novak GP, King KC. Lorazepam in the treatment of refractory neonatal seizures. J Child Neurol 1991; 6: 319-23
33. McDermott CA, Kowalczyk AL, Schnitzler ER, et al. Pharmacokinetics of lorazepam in critically ill neonates with seizures. J Pediatr 1992; 120: 479-83
34. Greenblatt DJ, Shader RI, Franke K, et al. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci 1979; 68: 57-63
35. Relling MV, Mulhern NK, Dodge RK, et al. Lorazepam pharmacokinetics and pharmacodynamics in children. J Pediatr 1989; 114: 641-6
36. Cronin CM. Neurotoxicity of lorazepam in a premature infant. Pediatrics 1992; 89: 1129
37. Reiter PD, Stiles AD. Lorazepam toxicity in a premature infant. Ann Pharmacother 1993; 27: 727-9
38. Gershanik JJ, Boecler B, Ensley H, et al. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982; 307: 1384-8
39. Reves JG, Fragen RJ, Vinik HR, et al. Midazolam: pharmacology and uses. Anesthesiology 1985; 62: 310-24
40. Jacqz-Aigrain E, Wood C, Robieux I. Pharmacokinetics of midazolam in critically ill neonates. Eur J Clin Pharmacol 1990; 39: 191-2
41. Jacqz-Aigrain E, Daoud P, Burtin P, et al. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. Eur J Clin Pharmacol 1992; 42: 329-32
42. Burtin P, Jacqz-Aigrain E, Girard P, et al. Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther 1994; 56: 615-25
43. Hartwig S, Roth B, Theisohn M. Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. Eur J Pediatr 1991; 150: 784-8
44. Van den Anker JN, Sauer PJJ. The use of midazolam in the preterm neonate [letter]. Eur J Pediatr 1992; 151: 152
45. Burtin P, Daoud P, Jacqz-Aigrain E, et al. Hypotension with midazolam and fentanyl in the newborn. Lancet 1991; 337: 1545-6
46. Van Straaten HLM, Rademaker CMA, de Vries LS. Comparison of the effect of midazolam or vecuronium on blood pressure and cerebral blood flow velocity in the premature newborn. Dev Pharmacol Ther 1992; 19: 191-5
47. Magny JF, d'Allest AM, Nedelcoux H, et al. Midazolam and myoclonus in neonate. Eur J Pediatr 1994; 153: 389-92
48. Bergman I, Steeves M, Burckart G, et al. Reversible neurological abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr 1991; 119: 644-9
49. Wood C, Oriot D, Robieux I, et al. Flumazénil : un antagoniste utile en Pédiatrie. Arch Fr Pédiatr 1988; 45: 149-50
50. Jones RDM, Chan K, Roulson CJ, et al. Pharmacokinetics of flumazenil and midazolam. Br J Anesth 1993; 70: 286-92
51. Cone AM, Nadel S, Sweeney B. Flumazenil reverses diazepam-induced neonatal apnoea and hypotonia [letter]. Eur J Pediatr 1993; 152: 458-9
52. Richard P, Autret E, Bardol J, et al. The use of flumazenil in a neonate. J Toxicol Clin Toxicol 1991; 29: 137-40
53. Marshall EK, Owens AH. Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. Bull Hosp John Hopkins 1954; 95: 1-18
54. Goldsmith JP. Ventilatory management casebook. J Perinatol 1994; 14: 74-6
55. Lambert GH, Muraskas J, Anderson CL, et al. Direct hyperbilirubinemia associated with chloral administration in the newborn. Pediatrics 1990; 86: 277-80
56. Jochemsen R, Breimer DD. Pharmacokinetics of benzodiazepine hynotics in man. Pharm Int 1984; 50: 244-8
57. Gorecki DKJ, Hindmarsh KW, Hall CA, et al. Determination of chloral hydrate metabolism in adult and neonatal biological fluids after single-dose administration. J Chromatogr B Biomed Appl 1990; 528: 333-41
58. Gershanik JJ, Boecler B, Lertora JL, et al. Monitoring levels of trichloroethanol (TCE) during chloral hydrate (CH) administration to sick neonates [abstract]. Clin Res 1981; 29: 895A
59. Reimche LD, Sankaran K, Hindmarsh KW, et al. Chloral hydrate sedation in neonates and infants: clinical and pharmacological considerations. Dev Pharmacol Ther 1989; 12: 7-64
60. Noerr B. Chloral hydrate. Neonat Netw 1992; 11: 69-71
61. Yaster M. Analgesia and anesthesia in neonates. J Pediatr 1987; 111: 394-6
62. Aitkenhead AR. Analgesia and sedation in intensive care. Br J Anaesth 1989; 63: 196-206
63. Pokela ML. Pain relief can reduce hypoxemia in distressed neonates during routine treatment procedures. Pediatrics 1994; 93: 379-83
64. Quinn MW, Wild J, Dean HG, et al. Randomised double-blind controlled trial of effect of morphine on catecholamine concentrations in ventilated pre-term babies. Lancet 1993; 342: 324-7
65. Goldstein RF, Brazy JE. Narcotic sedation stabilizes arterial blood pressure fluctuations in sick premature infants. J Perinatol 1991; 11: 365-71
66. Kauffman RE. Fentanyl, fads, and folly: who will adopt the therapeutic orphans? J Pediatr 1991; 119: 588-9
67. Coulter DM. Use of fentanyl in neonates. J Pediatr 1992; 120: 659-60
68. Marlow N, Weindling AM, Cooke RWI. Hazards of analgesia for newborn infants. Arch Dis Child 1988; 63: 1293-8
69. Koren G, Butt W, Chinyanga H, et al. Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety. J Pediatr 1985; 107: 963-7
70. Säwe J, Kager L, Svensson, JO, et al. Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. Br J Clin Pharmacol 1985; 19: 495-501
71. Osborne R, Joel S, Trew D, et al. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 1990; 47: 12-9
72. Gong QL, Hedner T, Hedner J, et al. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol 1991; 193: 47-56
73. Bhat R, Abu-Harb M, Chari G, et al. Morphine metabolism in acutely ill preterm newborn infants. J Pediatr 1942; 120: 795-99
74. Choonara IA, McKay P, Hain R, et al. Morphine metabolism in children. Br J Clin Pharmacol 1989; 28: 599-604
75. Choonara I, Lawrence A, Michalkiewicz A, et al. Morphine metabolism in neonates and infants. Br J Clin Pharmacol 1992; 34: 434-7
76. Choonara IA, Ekbom Y, Lindström B, et al. Morphine sulphation in children. Br J Clin Pharmacol 1990; 30: 897-900
77. McRorie TI, Lynn AM, Nespeca MK, et al. The maturation of morphine clearance and metabolism. Am J Dis Child 1992; 146: 972-6
78. Lynn AM, Slattery JT. Morphine pharmacokinetics in early infancy. Anesthesiology 1987; 66: 136-9
79. Bhat R, Chari G, Gulati A, et al. Pharmacokinetics of a single dose of morphine in preterm infants during the first week of life. J Pediatr 1990; 117: 477-81
80. Barrett DA, Elias-Jones AC, Rutter N, et al. Morphine kinetics after diamorphine infusion in premature neonates. Br J Clin Pharmacol 1991; 32: 31-7
81. Chay PCW, Duffy BJ, Walker JS. Pharmacokinetic-pharmacodynamic relationship of morphine in neonates. Clin Pharmacol Ther 1992; 51: 334-42
82. Hartley R, Green M, Quinn M, et al. Pharmacokinetics of morphine infusion in neonates. Arch Dis Child 1993; 69: 55-8
83. Pokela ML, Olkkola KT, Seppälä T, et al. Age-related morphine kinetics in infants. Dev Pharmacol Ther 1993; 20: 26-34
84. Mikkelsen S, Feilberg VL, Christensen CB, et al. Morphine pharmacokinetics in premature and mature newborn infants. Acta Paediatr 1994; 83: 1025-8
85. Olkkola KT, Maunuksela EL, Korpela R, et al. Kinetics and dynamics of postoperative intravenous morphine in children. Clin Pharmacol Ther 1988; 44: 128-35
86. Lynn AM, Opheim KL, Tyler DT. Morphine infusion after pediatric cardiac surgery. Crit Care Med 1984; 12: 863-6
87. Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther 1965; 6: 454-61
88. Lynn AM, Kay Nespeca M, Opheim KE, et al. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg 1993; 77: 695-701
89. Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 1983; 8: 422-46
90. Clotz MA, Nahata MC. Clinical uses of fentanyl, sufentanil and alfentanil. Clin Pharmacol 1991; 10: 581-93
91. Kochntop DE, Rodman JH, Brundage DM, et al. Pharmacokinetics of fentanyl in neonates. Anesth Analg 1986; 65: 227-32
92. Gauntlett IS, Fisher DM, Hertzka RE, et al. Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 1988; 69: 683-7
93. Johnson KL, Erickson JP, Holley FO et al. Fentanyl pharmacokinetics in the pediatric population [abstract]. Anesthesiology 1984; 61: A441
94. Singleton MA, Rosen JI, Fisher DM. Pharmacokinetics of fentanyl for infants and adults [abstract]. Anesthesiology 1984; 61: A440
95. Collins C, Koren G, Crean P, et al. Fentanyl pharmacokinetics and hemodynamic effects in preterm infants during ligation of patent ductus arteriosus. Anesth Analg 1985; 64: 1078-80
96. Arnold JH, Truog RD, Orav EJ, et al. Tolerance and dependence in neonates sedated with fentanyl during estracorporeal membrane oxygenation. Anesthesiology 1990; 73: 1136-40
97. Arnold JH, Truog RD, Scavone JM, et al. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr 1991; 119: 639-43
98. Dewey WL. Various factors which affect the rate of development of tolerance and physical dependence to abused drugs. NIDA Res Monogr 1984; 54: 39-49
99. Katz R, Kelly HW, Hsi A. Prospective study of the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med 1994; 22: 763-7
100. Yaster M. The dose response of fentanyl in neonatal anesthesia. Anesthesiology 1987; 66: 433-5
101. Hickey PR, Hansen DD, Wessel DL, et al. Pulmonary and systemic hemodynamic responses to fentanyl in infants. Anesth Analg 1985; 64: 483-6
102. Hickey PR, Hansen DD, Wessel DL, et al. Blunting of stress responses in the pulmonary circulation of infants by fentanyl. Anesth Analg 1985; 64: 1132-4
103. Murat I, Levron JC, Berg A, et al. Effects of fentanyl on baroreceptor reflex control of heart rate in newborn infants. Anesthesiology 1988; 68: 717-22
104. Lajarrige C, Adafer M, Mouthemy G, et al. Effet du fentanyl sur la ventilation du prématuré. Arch Fr Pédiatr 1993; 50: 271-4
105. Jarvis AP, Arancibia CU. A case of difficult neonatal ventilation [abstract]. Anesth Analg 1987; 66: 196
106. Davis PJ, Killian A, Stiller RL, et al. Pharmacokinetics of alfentanil in newborn premature infants and older children. Dev Pharmacol Ther 1989; 13: 21-7
107. Meistelman C, Saint-Maurice C, Lepaul M, et al. A comparison of alfentanil pharmacokinetics in children and adults. Anesthesiology 1987; 66: 13-6
108. Marlow N, Weindling AM, Van Peer A, et al. Alfentanil pharmacokinetics in preterm infants. Arch Dis Child 1990; 65: 349-51
109. Wiest DB, Ohning BL, Garner SS. The disposition of alfentanil min neonates with repiratory distress. Pharmacotherapy 1991; 11: 308-11
110. Killian A, Davis PJ, Stiller RL, et al. Influence of geslational age on the pharmacokinetics of alfentanil in neonales. Dev Pharmacol Ther 1990; 15: 82-5
111. Pokela ML, Ryhänen PT, Koivisto ME, et al. Alfentanil-induced rigidity in newborn infants. Anesth Analg 1992; 75: 252-7
112. Meistelman C, Benhamou D, Barre J, et al. Effects of age on plasma protein binding of sufentanil. Anesthesiology 1990; 72: 470-3
113. Greeley WJ, DeBruijn NP, Davis DP. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesth Analg 1987; 66: 1067-72
114. Greeley WJ, DeBruijn NP. Changes in sufentanil pharmacokinetics within the neonatal period. Anesth Analg 1988; 67: 86-9
115. Morselli PL, Rovei V. Placental transfer of pethidine and norpethidine and their pharmacokinetics in the newborn. Eur J Clin Pharmacol 1980; 18: 25-30
116. Caldwell J, Notarianni LJ, Smith RL. Impaired metabolism of pethidine in the human neonate. Br J Clin Pharmacol 1978; 5: 362-3
117. Pokela ML, Olkkola KT, Koivisto M, et al. Pharmacokinetics and pharmacodynamics of intravenous meperidine in neonates and infants. Clin Pharmacol Ther 1992; 2: 342-9
118. Stile IL, Fort M, Wurzburger RJ, et al. The pharmacokinetics of naloxone in the premature newborn. Dev Pharmacol Ther 1987; 10: 454-9
119. American Academy of Pediatrics Committee on Drugs. Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children. Pediatrics 1990; 86: 484-5
120. Ryan JP, Meakin G. Fentanyl overdose in a neonate: use of naloxone infusion [letter]. Anaesthesia 1989; 44: 864-5
121. Saint-Maurice C, Cockshott ID, Douglas EJ, et al. Pharmacokinetics of propofol in young children after a single bolus dose. Br J Anesth 1989; 63: 667-70
122. Jones RDM, Chan K, Andrew IJ. Pharmacokinetics of propofol in children. Br J Anesth 1990; 65: 661-7
123. Kataria BK, Ved SA, Nicodemus HF, et al. Pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology 1994; 80: 104-22
124. Smith I, White PF, Nathanson M, et al. Propofol: an update on its clinical use. Anesthesiology 1994; 81: 1005-41
125. Park TJ, Stevens JE, Greenaway CL, et al. Metabolic acidosis and fatal cardiac failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-6
126. Barclay K, Williams AJ, Major E. Propofol infusion in children [letter]. BMJ 1992; 305: 953
127. Bray RJ. Fatal myocardial failure associated with a propofol infusion in a child [letter]. Anesthesia 1995; 50: 494
128. Imray JM, Hay A. Withdrawal syndrome after propofol [letter]. Anesthesia 1991; 46: 704
129. Trotter C, Serpell MG. Neurological sequelae in children after prolonged propofol infusion. Anesthesia 1992; 47: 340-2
130. Lannigan C, Sury M, Bingham R, et al. Neurological sequelae in children after prolonged propofol infusion [letter]. Anesthesia 1992; 47: 810-1
131. Wolf AR. Neonatal sedation: more art than science. Lancet 1994; 344: 628-9